Schott: Expansion Of Syringe Manufacturing Capacity®

SCHOTT forma vitrum has tripled its production capacity with glass and polymer syringes in St. Gallen, Switzerland.

The international manufacturer of pharmaceutical packaging has invested around 20 million euros to glass forming, infrastructure, clean rooms and WFI facilities (water for injection purposes).

The new production facilities are based on state-of-the-art technology. In addition, several accompanying measures were taken to further improve the flow of goods and optimize customer service following expansion.

600450 Schott: Expansion Of Syringe Manufacturing Capacity®
Date: 29 May 2007
Source: Schott

See more news about:

See more from these topics:

Others also read

The 14th Otto Schott Research Award recognizes three researchers for their diverse findings on the strength of glass.
The 14th Otto Schott Research Award honors three researchers from three continents for their groundbreaking findings on the strength of glass
Since early researchers first became aware of their potentially deadly effects, the only confirmed form of protection available to those who were required to work with X-rays, gamma rays and similar emissions, was to conceal themselves behind lead sheeting or concrete walls.
SCHOTT PYRANOVA® integrity and insulation fire-resistant glass is being stocked for the first time at SCHOTT UK in Stafford.
SCHOTT’s glass wafers and substrates are transforming radio frequency components and micro-electromechanical systems. Advanced materials from SCHOTT, the international technology group and specialty glass experts, are shaking up the electronics industry.
New multimedia platform highlights innovations made possible with glass - SCHOTT, the international technology group, has launched an online platform that showcases the innovative potential of glass.

Add new comment